Wells Fargo Maintains Overweight on Ovintiv, Lowers Price Target to $78

Benzinga · 3d ago
Wells Fargo analyst Sam Margolin maintains Ovintiv (NYSE:OVV) with a Overweight and lowers the price target from $80 to $78.